What does this research mean for the field?

Autologous platelet-rich plasma (PRP) is an effective adjunctive therapy for small-area deep second-degree burns. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

To investigate the effectiveness and underlying mechanisms of platelet-rich plasma in treating deep second-degree burns.

February 27, 2026

Exploration of the Therapeutic Protocols and Underlying Molecular Mechanisms of Autologous Platelet-Rich Plasma in the Treatment of Deep Second-Degree Burns.

Key Points

To investigate the effectiveness and underlying mechanisms of platelet-rich plasma in treating deep second-degree burns.
Assessment of platelet-rich plasma as a therapy for deep second-degree burns
Comparison of early application versus late application of PRP
Analysis of PRP formulations with varying leukocyte content
Early application of leukocyte-poor PRP shows better outcomes
Frequent treatments do not improve healing and may be counterproductive
Controlled modulation of growth factors enhances therapeutic benefit

Abstract

PRP is an effective adjunctive therapy for small-area deep second-degree burns. Early application and leukocyte-poor PRP appear optimal, whereas indiscriminately increasing treatment frequency is not recommended. Controlled modulation of PRP-derived growth factors may be key to maximizing therapeutic benefit.

Bookmark

Cite This Study

Shi et al. (Sun,) studied this question.

synapsesocial.com/papers/69a1352fed1d949a99abec73 https://doi.org/https://doi.org/10.1111/jocd.70751

Bookmark